2026

Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.

Subissi L, Otieno JR, Ruis C, Rabe I, Agrawal A, Abu-Raddad LJ, Azhar EI, Beer M, Bezerra H, Caly L, Chand M, Companioni A, de Oliveira T, Dietrich I, Drosten C, Duran P, Faria NR, Fowotade A, Gresh L, Huang B, Kindrachuk J, Koopmans MPG, Korber B, Leo YS, Mbala-Kingebeni P, McMenamin M, Melhem NM, Munster VJ, Nunes BTD, Oude Munnink BB, Naveca FG, Peiris M, Palacios G, Resende P, Rodriguez A, Saha S, Suzuki T, Vicari A, von Gottberg A, Yadav P, Mendez-Rico J, Van Kerkhove MD, Rojas DP.

EClinicalMedicine. 2026.

PMID: 42058505

 

Questionnaire-based analysis of infection control and prevention strategies against COVID-19 in hematopoietic stem cell transplantation units in Japan, 2023.

Sakoh T, Morishima M, Suzuki T, Uchida N, Araoka H.

Jpn J Infect Dis. 2026.

PMID: 42055690

 

Modeling human enterovirus A71 infection using an intestinal microphysiological system.

Futatsusako H, Deguchi S, Kosugi K, Hashimoto R, Nagata N, Suzuki T, Yamamoto T, Takayama K.

J Virol. 2026.

PMID: 42012182

 

Multimerization of secretory IgA enhances antiviral activity by aggregating influenza A virus particles.

Yamauchi K, Muramoto Y, Fujita-Fujiharu Y, Hirabayashi A, Nogami C, Ishida T, Sugita Y, Saito S, Sano K, Suzuki T, Nakano M, Noda T.

Commun Biol. 2026.

PMID: 41986602

プレスリリース：分泌型IgAの多量体化は、A型インフルエンザウイルス粒子を凝集させることで抗ウイルス活性を増強する

 

Assessing the effectiveness of embalming in cadavers with COVID-19 after full autopsy and minimally invasive autopsy.

Saitoh H, Nagasawa S, Mori A, Hirata Y, Katano H, Ushiwata K, Torimitsu S, Nakajima M, Tsuneya S, Kobayashi S, Yamamoto I, Nakagawa K, Hasegawa I, Akitomi S, Sakurada K, Suzuki T, Iwase H, Hashizume K, Makino Y.

Forensic Sci Med Pathol. 2026.

PMID: 41961192

 

Complete genome sequence of a Streptococcus equi subsp. equi bacteriophage isolated from raw sewage water in Tokyo.

Shirakawa K, Kawamoto K, Kondo K, Ojima S, Kinoshita Y, Niwa H, Kataoka M, Suzuki T, Ueno T, Sugawara Y, Watashi K, Sugai M, Kiga K, Sato'o Y.

Microbiol Resour Announc. 2026.

PMID: 41784546

 

Emerging Multi-Source Transmission of SFTS Virus on a Remote Japanese Island: A One-Health Perspective.

Oshiro R, Ihara M, Ibrahim CHO, Matsui K, Dalouny X, Pham Vu NH, Kurashige T, Xu Q, Hu S, Ngwe Tun MM, Takaki Y, Ogushi H, Setoguchi D, Katsuoka S, Murakami T, Matsumoto C, Hattori M, Hattori N, Miyamoto S, Sakai Y, Suzuki T, Yamanashi H, Murota H, Maeda T, Morita K, Yoshikawa A, Takamatsu Y.

Int J Mol Sci. 2026.

PMID: 41751839

 

Pathology and viral evolutionary dynamics in a hamster model of persistent SARS-CoV-2 infection.

Wei W, Kuroda M, Liu Y, Iida S, Kandel S, Machovech H, Hirata Y, Suzuki T, Koelle K, Wang Z, Friedrich TC, Kawaoka Y, Halfmann PJ.

Commun Biol. 2026.

PMID: 41501552

 

2025

A Case of Cerebellar-Onset Progressive Multifocal Leukoencephalopathy (PML) Associated with Hepatitis B-related Liver Cirrhosis.

Sato K, Saito A, Miyazaki T, Nakamichi K, Takahashi K, Katano H, Suzuki T, Terasawa Y.

Intern Med. 2025.

PMID: 41224270

 

Isolation and characterization of bacteriophages for carbapenem resistant Enterobacter cloacae complex strains.

Imanaka M, Yamashita W, Ojima S, Azam AH, Kataoka M, Suzuki T, Sugawara Y, Sugai M, Takahashi Y, Watashi K, Tsuneda S, Kiga K.

Sci Rep. 2025.

PMID: 41198758

 

Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Park H, Nakamura N, Miyamoto S, Sato Y, Kim KS, Kitagawa K, Kobashi Y, Tani Y, Shimazu Y, Zhao T, Nishikawa Y, Omata F, Kawashima M, Abe T, Saito Y, Nonaka S, Takita M, Yamamoto C, Morioka H, Kato K, Sagou K, Yagi T, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Shibata RY, Aihara K, Kodama T, Kamiyama A, Tamura T, Fukuhara T, Shibuya K, Suzuki T, Iwami S, Tsubokura M.

Sci Transl Med. 2025.

PMID: 40961221

プレスリリース：新型コロナワクチンの継続的な接種を優先すべきは誰か？　～抗体応答不良の集団特定で接種戦略を最適化、感染拡大・重症化抑制へ～
 

Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.

Nakano M, Miyamoto S, Ohnishi C, Nogami C, Hirose N, Fujita-Fujiharu Y, Muramoto Y, Noda T.

J Virol. 2025.

PMID: 40919898

 

Fulminant Viral Myocarditis Associated with Thogotovirus.

Osawa S, Miyazaki K, Mine S, Hirata Y, Terada N, Ozawa M, Kikuchi K, Uchida A, Hirose K, Imakawa Y, Komuro K, Nagata N, Abe S, Uchida Y, Yanaoka T, Ozono S, Yoshikawa T, Lim CK, Fukushi S, Matsuu A, Miyamoto S, Kataoka M, Katano H, Maeda K, Ebihara H, Suzuki T.

N Engl J Med. 2025.

PMID: 40902171

プレスリリース：トゴトウイルス感染に関連した劇症型ウイルス性心筋炎による致死的病態の解明

 

Isolation and characterization of novel bacteriophages targeting Stenotrophomonas maltophilia.

Yamashita W, Sato Y, Imanaka M, Kataoka M, Suzuki T, Azam AH, Ojima S, Hayakawa K, Saito S, Moriyama Y, Ohmagari N, Kurokawa M, Mezaki K, Tamura A, Cui L, Fujiki J, Iwano H, Takahashi Y, Watashi K, Tsuneda S, Kiga K.

Sci Rep. 2025.

PMID: 40804103

 

Identification of Novel Wraparound Transcripts in JC Polyomavirus.

Iida S, Takahashi K, Mine S, Suzuki T, Katano H.

J Med Virol. 2025.

PMID: 40788165

 

Localization of parvovirus B19 in the renal allografts of healthy donors.

Inoue D, Oda T, Suzuki T, Kataoka M, Iwama S, Dohi Y, Konno O, Yamada M, Takeuchi H, Iwamoto H.

Virchows Arch. 2025.

PMID: 40783628

 

Comparison of Infection-Induced SARS-CoV-2 Seroprevalence Across Large-Scale Residual Samples From Blood Donors, Commercial Laboratories, and Health Checkups in Japan, 2023.

Nishigaki A, Kinoshita R, Sakuraba S, Sugihara J, Suzuki T, Suzuki M, Yoneoka D.

Open Forum Infect Dis. 2025.

PMID: 40765712

 

What Drives Respondents to Seroepidemiological Surveys? Insights From COVID-19 and Implications for Future Pandemics.

Ith S, Kinoshita R, Miyamoto S, Tomo Y, Arashiro T, Arai S, Sakuraba S, Sugihara J, Wakita T, Suzuki T, Suzuki M, Yoneoka D.

J Epidemiol. 2026.

PMID: 40754451

 

A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission.

Ruis C, Lusamaki E, O'Toole A, Otieno JR, Colquhoun R, Roemer C, Wawina-Bokalanga T, Tshiani-Mbaya O, Jansen D, Makangara JC, Agrawal A, Abu-Raddad LJ, Ahuka-Mundeke S, Ayouba A, Azhar EI, Caly L, Drosten C, Faria NR, Fowotade A, Hoxha A, Huang B, Korber B, le Polain de Waroux O, Lewis RF, Liesenborghs L, Melhem NM, Munster VJ, Ogoina D, Oude Munnink BB, Peiris JSM, Palacios G, Peeters M, Resende P, Rimoin AW, Saha S, Leo YS, Suzuki T, Vercauteren K, Yadav P, Van Kerkhove MD, Neher R, de Oliveira T, Ulaeto D, Mbala-Kingebeni P, Kindrachuk J, Koopmans MPG, Chand M, von Gottberg A, Subissi L, Rambaut A.

Nat Med. 2025.

PMID: 40731088

 

Three Cases of Vertical Transmission of Clade Ib Mpox Virus.

Vakaniaki EH, Kuispond NS, Hirata Y, Bangwen E, Brosius I, Kinganda-Lusamaki E, Ozono S, Katano H, Ndunge LG, Mulopo-Mukanya N, Tshomba JC, De Vos E, Van Dijck C, Munganga P, Mukari G, Mujula Y, Mambo DM, Kitwanda SB, Maliyamungu-Bubala N, Mutimbwa-Mambo L, Crozier I, Dodd LE, Tshiani-Mbaya O, Lebwaze BM, Malembaka EB, Barhishindi I, Krasemann S, Colebunders R, Katoto PDMC, Makiala-Mandanda S, Kindrachuk J, Rimoin AW, Muyembe-Tamfum JJ, Mukadi-Bamuleka D, Wawina-Bokalanga T, Nundu SS, Suzuki T, Chirimwami RB, Liesenborghs L, Mbala-Kingebeni P.

N Engl J Med. 2025.

PMID: 40532158

プレスリリース：エムポックスウイルス（クレードIb）の妊婦感染症例の解析を実施 －国際共同研究により、エムポックスウイルスが胎盤を介して胎児に先天性感染することを発見－

 

A pluralistic approach to interpreting surveillance data: The likely decline in the occurrence of invasive pneumococcal disease in Japan during the COVID-19 pandemic.

Shimbashi R, Arima Y, Yahara K, Masutani M, Kasamatsu A, Fukusumi M, Kajihara T, Arashiro T, Takahashi T, Otsuka M, Kobayashi Y, Komase K, Tsuchihashi Y, Chang B, Amemura-Maekawa J, Sunagawa T, Suzuki M, Akeda Y.

Ann Epidemiol. 2025.

PMID: 40527438

 

Experience conducting COVID-19 vaccine effectiveness studies in response to the COVID-19 pandemic in Japan and the Philippines: lessons for future epidemics and potential pandemics.

Arashiro T, Berba RP, Calayo JP, Solante R, Suzuki S, Shin J, Suzuki M, Hibberd M, Ariyoshi K, Smith C.

Western Pac Surveill Response J. 2025.

PMID: 40497080

 

Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens.

Isogawa M, Onodera T, Ainai A, Kotaki R, Kanno T, Saito S, Tobiume M, Tokunaga K, Hara M, Hirota Y, Suzuki T, Takahashi Y, Tsuru T.

Sci Rep. 2025.

PMID: 40436912

 

Hidden challenges in evaluating spillover risk of zoonotic viruses using machine learning models.

Kawasaki J, Suzuki T, Hamada M.

Commun Med (Lond). 2025.

PMID: 40394176

 

Histomorphological variations in progressive multifocal leukoencephalopathy correlated with JCV replication in brain lesions: insights from 91 patients.

Takahashi K, Sato Y, Hasegawa H, Katano H, Suzuki T.

Acta Neuropathol Commun. 2025.

PMID: 40390121

 

Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history.

Miyamoto S, Numakura K, Kinoshita R, Arashiro T, Takahashi H, Hibino H, Hayakawa M, Kanno T, Sataka A, Sakamoto R, Ainai A, Arai S, Suzuki M, Yoneoka D, Wakita T, Suzuki T.

Commun Med (Lond). 2025.

PMID: 40374831

プレスリリース：大規模血清疫学調査から新型コロナウイルス再感染防御と血中抗体価の関係を解明 ―核タンパク質抗体価が無症候性感染も含めた感染防御の指標となることを実証―

 

Progressive multifocal leukoencephalopathy during 4 years of Palbociclib for advanced breast cancer with a history of follicular lymphoma patient.

Koyamada R, Nishihara M, Masaki T, Shimada T, Ishikawa K, Hashimoto J, Mori N, Namai A, Yokoo H, Takahashi K, Suzuki T, Nakamichi K, Mori S.

J Neurovirol. 2025.

PMID: 40259166

 

Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients.

Iriyama C, Ichikawa T, Tamura T, Takahata M, Ishio T, Ibata M, Kawai R, Iwata M, Suzuki M, Adachi H, Nao N, Suzuki H, Kawai A, Kamiyama A, Suzuki T, Hirata Y, Iida S, Katano H, Ishii Y, Tsuji T, Oda Y, Tanaka S, Okazaki N, Katayama Y, Nakagawa S, Tsukamoto T, Doi Y, Fukuhara T, Murata T, Tomita A.

PNAS Nexus. 2025.

PMID: 40160532

 

Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models.

Oba S, Hosoya T, Kawata D, Komiya Y, Iwai H, Koike R, Miyamoto S, Kanno T, Ainai A, Suzuki T, Hasegawa H, Yasuda S.

Eur J Pharmacol. 2025.

PMID: 40147575

 

Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.

Anraku Y, Kita S, Onodera T, Sato A, Tadokoro T, Ito S, Adachi Y, Kotaki R, Suzuki T, Sasaki J, Shiwa-Sudo N, Iwata-Yoshikawa N, Nagata N, Kobayashi S, Kazuki Y, Oshimura M, Nomura T, Sasaki M, Orba Y, Suzuki T, Sawa H, Hashiguchi T, Fukuhara H, Takahashi Y, Maenaka K.

Commun Biol. 2025.

PMID: 40121330

 

Pathological characterization of female reproductive organs prior to miscarriage induced by Zika virus infection in the pregnant common marmoset.

Imagawa T, Tanaka K, Ito M, Matsuda M, Suzuki T, Ando T, Yaguchi C, Miyamoto K, Takabayashi S, Suzuki R, Takasaki T, Itoh H, Kosugi I, Suzuki T.

Microbiol Spectr. 2025.

PMID: 39998269

 

Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination.

Fujisawa M, Onodera T, Kuroda D, Kewcharoenwong C, Sasaki M, Itakura Y, Yumoto K, Nithichanon A, Ito N, Takeoka S, Suzuki T, Sawa H, Lertmemongkolchai G, Takahashi Y.

NPJ Vaccines. 2025.

PMID: 39988605

 

LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.

Okumura N, Morino E, Nomoto H, Yanagi M, Takahashi K, Iwasaki H, Uemura Y, Shimizu Y, Mizushima D, Fukushima K, Kinai E, Shiojiri D, Itoda I, Onoe Y, Kobori Y, Nakamura F, Tokita D, Sugiura W, Ueno S, Ainai A, Mine S, Suzuki T, Ohmagari N, Ujiie M.

Clin Infect Dis. 2026.

PMID: 39982831

 

Calboxyvinyl polymer adjuvant enhances respiratory iga responses through mucosal and systemic administration.

Sasaki E, Asanuma H, Momose H, Maeyama JI, Moriyama S, Nagata N, Suzuki T, Hamaguchi I, Hasegawa H, Takahashi Y.

NPJ Vaccines. 2025.

PMID: 39934182

 

Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study.

Kinoshita R, Miyamoto S, Suzuki T, Suzuki M, Yoneoka D.

JMIR Public Health Surveill. 2025.

PMID: 39931010

 

Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients.

Kamegai K, Itoh N, Ishikane M, Iwamoto N, Asai Y, Akazawa-Kai N, Fuwa N, Takasaki J, Hojo M, Hangaishi A, Togano T, Teruya K, Takahashi K, Miyamoto S, Hirata Y, Kanno T, Saito T, Katano H, Suzuki T, Ohmagari N.

J Infect Chemother. 2025.

PMID: 39848541

 

Neutrophil adhesion to vessel walls impairs pulmonary circulation in COVID-19 pathology.

Ueki H, Wang IH, Kiso M, Horie K, Iida S, Mine S, Ujie M, Hsu HW, Wu CH, Imai M, Suzuki T, Kamitani W, Kawakami E, Kawaoka Y.

Nat Commun. 2025.

PMID: 39805823

 

A Mouse Model of Ovalbumin-Induced Airway Allergy Exhibits Altered Localization of SARS-CoV-2-Susceptible Cells in the Lungs, Which Reflects Omicron BA.5 Infection Dynamics, Viral Mutations, and Immunopathology.

Iketani T, Miyazaki K, Iwata-Yoshikawa N, Sakai Y, Shiwa-Sudo N, Ozono S, Asanuma H, Hasegawa H, Suzuki T, Nagata N.

Microbiol Immunol. 2025.

PMID: 39572887